Abstract
The androgen receptor (AR) is critical for the progression of prostate cancer to a castration-resistant (CRPC) state. AR antagonists are ineffective due to their inability to repress the expression of AR or its splice variant, AR-V7. Here, we report that the tyrosine kinase ACK1 (TNK2) phosphorylates histone H4 at tyrosine 88 upstream of the AR transcription start site. The WDR5/MLL2 complex reads the H4-Y88-phosphorylation marks and deposits the transcriptionally activating H3K4-trimethyl marks promoting AR transcription. Reversal of the pY88-H4 epigenetic marks by the ACK1 inhibitor (R)-9bMS-sensitized naive and enzalutamide-resistant prostate cancer cells and reduced AR and AR-V7 levels to mitigate CRPC tumor growth. Thus, a feedforward ACK1/pY88-H4/WDR5/MLL2/AR epigenetic circuit drives CRPC and is necessary for maintenance of the malignant state.
Original language | English |
---|---|
Pages (from-to) | 790-803.e8 |
Journal | Cancer Cell |
Volume | 31 |
Issue number | 6 |
DOIs | |
State | Published - Jun 12 2017 |
Keywords
- ACK1
- AR
- AR-V7
- TNK2
- castration resistance
- enzalutamide
- epigenetics
- histone
- prostate cancer
- small-molecule inhibitor
- tyrosine phosphorylation